期刊
JOURNAL OF PHYSIOLOGY-LONDON
卷 597, 期 1, 页码 193-209出版社
WILEY
DOI: 10.1113/JP277002
关键词
diabetic nephropathy; renin-angiotensin-aldosterone system inhibitors; tubulointerstitial fibrosis; profibrotic growth factors; PDGF; CTGF
资金
- EEMOFA KT-2017
- MTA-SE Lendulet Research Grant [LP008/2017]
- [OTKA-K112629-K116928-FK124491-NN-11460]
- [VKE-2017-00006]
- [EFOP-3.6.3-VEKOP-16-2017-00009]
In diabetic kidney disease (DKD) increased activation of renin-angiotensin-aldosterone system (RAAS) contributes to renal fibrosis. Although RAAS inhibitors (RAASi) are the gold standard therapy in DKD, the mechanism of their antifibrotic effect is not yet clarified. Here we tested the antifibrotic and renoprotective action of RAASi in a rat model of streptozotocin-induced DKD. In vitro studies on proximal tubular cells and renal fibroblasts were also performed to further clarify the signal transduction pathways that are directly altered by hyperglycaemia. After 5 weeks of diabetes, male Wistar rats were treated for two more weeks per os with the RAASi ramipril, losartan, spironolactone or eplerenone. Proximal tubular cells were cultured in normal or high glucose (HG) medium and treated with RAASi. Platelet-derived growth factor (PDGF) or connective tissue growth factor (CTGF/CCN2)-induced renal fibroblasts were also treated with various RAASi. In diabetic rats, reduced renal function and interstitial fibrosis were ameliorated and elevated renal profibrotic factors (TGF beta 1, PDGF, CTGF/CCN2, MMP2, TIMP1) and alpha-smooth muscle actin (alpha SMA) levels were decreased by RAASi. HG increased growth factor production of HK-2 cells, which in turn induced activation and alpha SMA production of fibroblasts. RAASi decreased tubular PDGF and CTGF expression and reduced production of extracellular matrix (ECM) components in fibroblasts. In proximal tubular cells, hyperglycaemia-induced growth factor production increased renal fibroblast transformation, contributing to the development of fibrosis. RAASi, even in non-antihypertensive doses, decreased the production of profibrotic factors and directly prevented fibroblast activation. All these findings suggest a novel therapeutic role for RAASi in the treatment of renal fibrosis.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据